Gabapentin
Product Images NDC 68151-1030

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68151-1030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (68151 1030)

Label for Gabapentin 400 mg capsules displaying the proprietary name, dosage strength, dosage form, manufacturer as Actavis, and product NDC as 0078-6715. It includes an expiration date (09/16) and a barcode with the number 0000001030.*

FDA Label Image

2 (Gabapentin Capsules Elizabeth Edison 1)

Formula for estimating creatinine clearance (CLCr) based on age, weight, serum creatinine, and sex. The calculation includes a factor adjustment for female patients (0.85) and uses variables: age in years, weight in kilograms, and serum creatinine in mg/dL.*

FDA Label Image

Rimprint (Gabapentin Capsules Elizabeth Edison 2)

Gabapentin 600 mg capsules package label from Carilion Materials Management. The label displays the product name and strength prominently, with dosage form as capsules indicated. The label also includes the product NDC 68151-1030 and other regulatory information typical for pharmaceutical packaging.*

FDA Label Image

Rimprint (Gabapentin Capsules Elizabeth Edison 3)

Gabapentin 300 mg capsules bottle label from Carilion Materials Management. The white container displays the product name, strength, dosage form (capsules), and manufacturer. The label includes dosage instructions stating to take one capsule by mouth three times daily.*

FDA Label Image

Rimprint (Gabapentin Capsules Elizabeth Edison 4)

Gabapentin 300 mg capsules in a white and blue bottle with child-resistant cap from Carilion Materials Management. The label shows the proprietary name Gabapentin, active ingredient strength 300 mg, capsule dosage form, and includes the product NDC 68151-1030. The label also contains typical prescription drug warnings and pharmacy information.*

FDA Label Image

1 (Gabapentin Capsules Elizabeth Edison 5)

Chemical structure of gabapentin, showing a cyclohexane ring attached to aminomethyl and acetic acid functional groups.*

FDA Label Image

1 (Gabapentin Capsules Elizabeth Edison 6)

Line graph comparing mean pain scores over 8 weeks for Gabapentin 3600 mg/day and placebo groups. The x-axis shows weeks from baseline to 8 with a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. Gabapentin group scores decrease over time, while placebo scores remain relatively stable.*

FDA Label Image

2 (Gabapentin Capsules Elizabeth Edison 7)

A line graph depicting mean pain score over seven weeks comparing placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. The x-axis represents weeks, including a 3-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. Both gabapentin doses show a greater decrease in mean pain score compared to placebo over time.*

FDA Label Image

3 (Gabapentin Capsules Elizabeth Edison 8)

A bar chart illustrating results from two studies comparing placebo (PBO) and Gabapentin (GBP) at different doses. Study 1 shows 12% for PBO and 29% for GBP 3600 mg. Study 2 shows 14% for PBO, 32% for GBP 1800 mg, and 34% for GBP 2400 mg, with statistical significance indicated by p-values less than 0.01 and 0.001.*

FDA Label Image

4 (Gabapentin Capsules Elizabeth Edison 9)

A scatter plot showing the relationship between daily dose (mg) and difference (%) for Gabapentin across three separate studies labeled as study a, study b, and study c. The x-axis represents daily dose in milligrams, and the y-axis represents percentage difference. Data points are distinguished by different colors and shapes corresponding to each study.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.